Abacus Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
25,215
-9,235
-27% -$110K 0.04% 216
2026
Q1
$206K Sell
34,450
-5,802
-14% -$43.7K 0.02% 470
2025
Q4
$289K Buy
+40,252
New +$318K 0.03% 354

Other funds holding OGN

Abacus Wealth Partners's OGN Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Organon & Co (OGN) stake by 27% in Q2 2026, selling an estimated $110K and leaving 25,215 shares worth $341K. The position accounts for 0.04% of the portfolio, ranked #216.

Abacus Wealth Partners first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Abacus Wealth Partners held 25,215 shares of Organon & Co worth $341K as of Q2 2026.
  • Abacus Wealth Partners sold 9,235 Organon & Co shares in Q2 2026, an estimated $110K.
  • Organon & Co made up 0.04% of Abacus Wealth Partners's portfolio in Q2 2026, its #216 holding.
  • Abacus Wealth Partners first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.